ME1100 inhalation solution

DRUG3 trials

Sponsors

Meiji Seika Pharma Co., Ltd.

Conditions

HealthyPneumonia, Bacterial

Phase 1

Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers

CompletedNCT01907776

Meiji Seika Pharma Co., Ltd.Healthy

Start: 2013-07-31Updated: 2014-06-12

Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers

CompletedNCT01961830

Meiji Seika Pharma Co., Ltd.Healthy

Start: 2013-09-30Updated: 2014-06-12

A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia

CompletedNCT02459158

Meiji Seika Pharma Co., Ltd.Pneumonia, Bacterial

Start: 2015-09-30End: 2017-03-22Updated: 2017-07-05